NCT03441971View on ClinicalTrials.gov

Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

April 13, 2020

Study Completion Date

March 31, 2030

Conditions
Heart Defects, CongenitalTetralogy of FallotPulmonary Valve InsufficiencyPulmonary Valve Stenosis
Interventions
DEVICE

GORE PV1

Implantation of GORE PV1 Device for procedure to replace the pulmonary valve and reconstruct the right ventricular outflow tract (RVOT).

Trial Locations (3)

43205

Nationwide Children's Hospital, Columbus

60611

Lurie Children's Hospital, Chicago

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT03441971 - Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction | Biotech Hunter | Biotech Hunter